Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
暂无分享,去创建一个
J. Stanford | D. Penson | A. Potosky | R. Stephenson | W. Davis | R. Hoffman | L. Harlan | Robert A. Stephenson | Arnold L. Potosky | William W Davis | Richard M. Hoffman | Janet L. Stanford | Linda C. Harlan
[1] P. Fransson,et al. Self‐assessed sexual function after pelvic irradiation for prostate carcinoma: Comparison with an age‐matched control group , 1996, Cancer.
[2] John T. Wei,et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[4] R A Stephenson,et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.
[5] D. Rubin,et al. Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .
[6] F. J. Fowler,et al. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma , 2002, Cancer.
[7] C. Waltz. Validation study. , 1988, NLN publications.
[8] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.
[9] B. Achinstein,et al. Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.
[10] Ronald C. Chen,et al. Time course and predictors of symptoms after primary prostate cancer therapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Cooperberg,et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. , 2003, Journal of the National Cancer Institute.
[12] J. Montie,et al. Trends in the utilization of androgen‐deprivation therapy for patients with prostate carcinoma suggest an effect on mortality , 2001, Cancer.
[13] J. Moul. Radical prostatectomy versus radiation therapy for clinically localized prostate carcinoma , 2002, Cancer.
[14] J. Stanford,et al. Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study. , 2000, Medical care.
[15] S G Pauker,et al. Screening for prostate cancer. A decision analytic view. , 1994, JAMA.
[16] H. D. de Koning,et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Luketich,et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. , 2000, Journal of the National Cancer Institute.
[18] N. Aaronson,et al. Review Article HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCER , 2003 .
[19] D. Fryback,et al. Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.
[20] P. Nguyen,et al. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma , 2002, Cancer.
[21] Juni Palmgren,et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2002, The New England journal of medicine.
[22] J. Stanford,et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. , 1999, Journal of the National Cancer Institute.
[23] C. Sherbourne,et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .
[24] D. Eton,et al. Prostate cancer and health‐related quality of life: a review of the literature , 2002, Psycho-oncology.
[25] R A Stephenson,et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.
[26] L. Koss. Localized prostate cancer and DNA ploidy. , 2005, JAMA.
[27] M. Barry,et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. , 1995, Urology.
[28] M. Roach. Radical prostatectomy or external beam radiotherapy , 2002, Cancer.
[29] D. Lubeck,et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. , 1999, Urology.
[30] A. Zietman,et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.
[31] E L Korn,et al. Predictive Margins with Survey Data , 1999, Biometrics.
[32] E. Giovannucci,et al. The association of treatment‐related symptoms with quality‐of‐life outcomes for localized prostate carcinoma patients , 2002, Cancer.
[33] S. Yao,et al. Population-based study of long-term survival in patients with clinically localised prostate cancer , 1997, The Lancet.
[34] J. Merz,et al. Older Patients' Willingness to Trade Off Urologic Adverse Outcomes for a Better Chance at Five‐Year Survival in the Clinical Setting of Prostate Cancer , 1995, Journal of the American Geriatrics Society.
[35] J Brennan,et al. Adjustment to cancer—coping or personal transition? , 2001, Psycho-oncology.
[36] J. Stanford,et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] J. Stanford,et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] L. Holmberg,et al. Quality of life after radical prostatectomy or watchful waiting. , 2002, The New England journal of medicine.
[39] J. Stanford,et al. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] R H Brook,et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. , 1998, Medical care.
[41] P. Walsh,et al. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. , 1993, The Journal of urology.
[42] E. Klein,et al. Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate. , 2003, Urology.
[43] E. Klein,et al. Defining sexual outcomes after treatment for localized prostate carcinoma , 2002, Cancer.